Share This Page
Drug Price Trends for SM ANTACID-ANTIGAS LIQUID
✉ Email this page to a colleague

Average Pharmacy Cost for SM ANTACID-ANTIGAS LIQUID
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
SM ANTACID-ANTIGAS LIQUID | 70677-0115-01 | 0.01055 | ML | 2025-01-22 |
SM ANTACID-ANTIGAS LIQUID | 70677-0115-01 | 0.01068 | ML | 2024-12-18 |
SM ANTACID-ANTIGAS LIQUID | 70677-0115-01 | 0.01064 | ML | 2024-11-20 |
SM ANTACID-ANTIGAS LIQUID | 70677-0115-01 | 0.01083 | ML | 2024-10-23 |
SM ANTACID-ANTIGAS LIQUID | 70677-0115-01 | 0.01093 | ML | 2024-09-18 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
The Global Antacids Market: Trends, Drivers, and Future Outlook
Introduction to the Antacids Market
The antacids market is a significant segment within the pharmaceutical industry, driven by the increasing prevalence of gastrointestinal disorders and changing lifestyle habits. Here, we delve into the current state, growth drivers, and future projections of the global antacids market.
Market Size and Growth Projections
As of 2022, the global antacids market was valued at approximately USD 6.6 billion and is anticipated to grow at a compound annual growth rate (CAGR) of 3.7% from 2023 to 2030, reaching USD 8.79 billion by 2030[1][5].
Key Growth Drivers
Several factors are driving the growth of the antacids market:
Changing Dietary Habits
Unhealthy food habits and sedentary lifestyles are leading to an increase in digestive issues, thereby boosting the demand for antacids[1][3].
Prevalence of Gastrointestinal Disorders
The rising incidence of gastroesophageal reflux disease (GERD), peptic ulcers, and other digestive disorders is a major driver. For instance, in 2019, 783.95 million people were diagnosed with GERD globally[1].
Convenience and Consumer Preferences
The development of consumer-centric formulations such as chewable and flavored tablets, as well as liquid antacids, is increasing convenience and palatability, especially for children and the elderly[1][5].
Lenient Legislations
Over-the-counter (OTC) availability of antacids, facilitated by lenient regulations, is enhancing their penetration through retail pharmacies, convenience stores, and online platforms[3].
Market Segmentation
By Formulation Type
- Tablets: Currently, tablets account for a significant share of the market, expected to generate sales of nearly USD 13 billion by 2025[3].
- Liquid: The liquid segment is anticipated to grow at a significant CAGR due to its ease of use and palatability, making it a preferred choice for children and the elderly[1][5].
- Others: This includes powders and other forms, which also contribute to the market but to a lesser extent.
By Distribution Channel
- Retail Pharmacies: Dominating the market in terms of revenue, retail pharmacies offer convenience and wide availability of antacids[5].
- Online Pharmacies: Expected to grow faster due to the rising popularity of online shopping, high penetration of smartphones, and improvements in telecom services[4].
- Hospital Pharmacies: Also a significant channel, especially for patients requiring antacids as part of their treatment regimen[1].
By Region
- North America: Accounts for a major share of the market due to well-developed healthcare infrastructure, high prevalence of gastrointestinal diseases, and easy availability of OTC medications[5].
- Europe: Expected to hold a significant market share by 2025, driven by consumer demand and market penetration[3].
- Asia-Pacific: Anticipated to witness notable growth due to the surge in demand and unmet medical needs of the large population in this region[5].
Consumer Preferences and Trends
Convenience and Palatability
Consumers are increasingly inclined towards antacids that offer convenience and palatability. Liquid antacids, for example, are preferred due to their ease of use and availability in various flavors[1][5].
Natural Treatments
There is a growing interest in natural treatments, which could potentially impact the sales of conventional antacids. However, this trend is still evolving and its full impact is yet to be seen[3].
Key Players and Competitive Landscape
Major players in the antacids market include Pfizer Inc., GlaxoSmithKline plc, Dabur, Bayer AG, Reckitt Benckiser Group PLC, and Haleon plc, among others. These companies are focusing on research and development to differentiate their products and increase their market share[1][5].
Technological Advancements and New Formulations
The development of new formulations, such as tablets that reduce gastric acid in patients with blood cancer, is expected to further boost market growth. For instance, AstraZeneca's new tablet formulation approved in August 2022 is a significant example of such innovation[1].
Challenges and Restraints
While the market is growing, it faces challenges such as the increasing interest in natural treatments and potential side effects associated with long-term use of antacids. However, these challenges are being addressed through continuous innovation and consumer education[3].
Regional Insights
North America
North America dominates the market due to its well-developed healthcare infrastructure and high prevalence of gastrointestinal diseases. The U.S. and Canada are key markets within this region[5].
Europe
Europe is another significant market, driven by consumer demand and the presence of key players. Countries like the UK, Germany, and France are major contributors to the European market[1].
Asia-Pacific
The Asia-Pacific region is expected to witness significant growth due to the large population and increasing demand for antacids. Countries like Japan, China, and India are key markets in this region[5].
Future Outlook
The antacids market is poised for continued growth driven by increasing demand for convenient and effective digestive remedies. Here are some key points to consider:
- Market Size: Expected to reach USD 8.79 billion by 2030 and USD 22 billion by 2033[1][4].
- Growth Rate: Anticipated CAGR of 3.7% from 2023 to 2030 and 4.6% from 2023 to 2033[1][4].
- Distribution Channels: Online pharmacies are expected to grow faster due to the rise in online shopping culture[4].
"The global antacids market size was estimated at USD 6.6 billion in 2022 and is anticipated to grow at a CAGR of 3.7% from 2023 to 2030"[1].
Key Takeaways
- The global antacids market is driven by changing dietary habits, the prevalence of gastrointestinal disorders, and consumer preferences for convenient and palatable formulations.
- The liquid segment is expected to grow significantly due to its ease of use and palatability.
- North America and Europe are leading regions, with Asia-Pacific expected to show notable growth.
- Key players are focusing on research and development to differentiate their products.
- Online pharmacies are expected to grow faster due to the rise in online shopping culture.
Frequently Asked Questions
Q: What is the current size of the global antacids market? A: The global antacids market size was estimated at USD 6.6 billion in 2022[1].
Q: What is the expected growth rate of the antacids market from 2023 to 2030? A: The market is anticipated to grow at a CAGR of 3.7% from 2023 to 2030[1].
Q: Which segment is expected to grow the fastest in the antacids market? A: The liquid segment is expected to grow at a significant CAGR due to its ease of use and palatability[1][5].
Q: What are the major distribution channels for antacids? A: Retail pharmacies, online pharmacies, and hospital pharmacies are the major distribution channels[1][5].
Q: Which region dominates the antacids market? A: North America currently dominates the market, but Asia-Pacific is expected to show notable growth in the future[5].
Sources
- Grand View Research: Antacids Market Size, Share & Growth Analysis Report, 2030.
- Drug Patent Watch: Pharmaceutical drug prices and trends for ANTACID-ANTIGAS LIQUID.
- Fact.MR: The Global Antacids Market Value to Surpass US$ 19 Bn by 2025.
- Fact.MR: Antacids Market Size, Share, Demand & Growth Analysis, 2033.
- Allied Market Research: Antacids Market Size & Share | Statistics Report [2023-2032].
More… ↓